Protein may help detect early pancreatic cancer

the ONA take:

A protein encoded in the glypican-1 (GPC1) gene may allow for a non-invasive screening tool to detect early pancreatic cancer, according to a study published in Nature.

Raghu Kalluri, MD, PhD, and fellow researchers from The University of Texas MD Anderson Cancer Center examined GPC1-enriched exosomes (GPC1+ crExos) from the blood of patients with pancreatic cancer.

“GPC1+ crExos were detected in small amounts of serum from about 25 patients with pancreatic cancer with absolute specificity and sensitivity, importantly distinguishing patients with chronic pancreatitis from those with early- and late-stage pancreatic cancer,” said Dr. Kalluri.

They found that GPC1+ crExos levels were significantly lower in patients upon surgical removal of the tumor. Cancer exosomes, they concluded, can be isolated to provide cancer-specific information in addition to acting as a biomarker.

With routine screening through the use of MRIs or CT scans being “prohibitively expensive,” the study authors believe that GPC1+ crExos may be used as an effective detection tool in combination with imaging.

Protein may help detect early pancreatic cancer
A protein encoded in the glypican-1 (GPC1) gene may allow for a non-invasive screening tool to detect early pancreatic cancer.
A protein encoded by the gene glypican-1 (GPC1) present on cancer exosomes may be used as part of a potential non-invasive diagnostic and screening tool to detect early pancreatic cancer, potentially at a stage amenable to surgical treatment.
READ FULL ARTICLE From Medical Express
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs